Between the very common and the very rare – An opinionated take on NEJM highlights for October 2017
Marc Herant
October 30, 2017
Between the very common and the very rare – An opinionated take on NEJM highlights for October 2017 Another tool for prevention in cardiovascular disease Taking aspirin daily has been standard of care for cardiovascular disease for decades, but attempts to demonstrate the additive usefulness of other agents to prevent clot formation have not been successful. Now things have changed: in a large study of patients with established cardiovascular disease, those who took rivaroxaban (Xarelto, Bayer) daily on top of aspirin did markedly better than with aspirin alone, although